A scientific team funded by the National Institutes of Health (NIH) has found new ways to improve the accuracy of a genetic testing method called a polygenic risk score.
WuXi Advanced Therapies (WuXi ATU), a subsidiary of WuXi AppTec, announced that its Philadelphia site has received FDA approval to begin analytical testing and manufacturing of Amtagvi for Iovance.
Researchers found more than 275 million previously unreported genetic variants in data shared by nearly 250,000 National Institutes of Health's Global Research Program participants.
Indian drug firms are exploring opportunities in the Kingdom of Saudi Arabia (KSA), an $8.9 billion pharmaceutical (pharma) market, as the latter is keen to procure more pharmaceutical products from India.
The pharma landscape has significantly shifted towards collaboration and partnership between global big pharma and Indian pharma firms in recent years to drive innovation and expand market reach.
The primary endpoint in the phase 3 registrational study (RESTORE-1) of IBI311, a recombinant anti-insulin-like growth factor 1 receptor (IGF-1R) antibody, in Chinese subjects with thyroid eye disease (TED) has been achieved, according to...
National Institute of Mental Health and Neuro Sciences (NIMHANS) ‘Mental Health Santhe 2.0 sets new standards in mental health awareness.
Dr Mansukh Mandaviya, Union minister of health and family welfare, urged all member countries of the World Health Organisation (WHO) to join hands to strengthen the global digital health framework, which will empower countries
GE HealthCare, a leading global medical technology, pharma diagnostics, and digital solutions innovator, has announced a collaboration with Illinois-headquartered OSF HealthCare for an integrated health system caring for patients
Bayer announced the initiation of a Phase 2 clinical trial (SIRIUS study) for BAY3018250, the first anti-alpha2 antiplasmin (anti-a2ap) antibody in patients with deep vein thrombosis (DVT).
, CDSCO.jpg)
.jpg)